Shares of Bayer CropScience Limited fell 7.49% to ₹4,429.30 on Tuesday after the company reported a 63.3% year-on-year (YoY) decline in net profit for Q3 FY25, despite a 10.7% YoY increase in revenue. The company’s Q3 revenue stood at ₹1,056.9 crore, up from ₹954.9 crore in the same period last year. However, net profit dropped sharply to ₹34.2 crore, compared to ₹93.1 crore in Q3 FY24, primarily due to higher expenses and lower margins.
The stock has a market capitalization of ₹199.33 billion, with a price-to-earnings (P/E) ratio of 34.32 and a dividend yield of 2.82%. The share price traded within a day range of ₹4,402.00 – ₹4,700.00, with a 52-week range of ₹4,402.00 – ₹7,196.85.
The company’s cost of materials consumed increased significantly to ₹691.3 crore in Q3 FY25, up from ₹363.9 crore in Q3 FY24, leading to a decline in profitability. Total expenses rose 24.9% YoY to ₹1,056.0 crore, driven by higher raw material and employee costs. Profit before tax (PBT) stood at ₹33.6 crore, marking a 73% YoY decline from ₹124.2 crore in Q3 FY24.
Bayer CropScience also announced major management changes. Mr. Simon Johannes Britsch, Whole-Time Director & CFO, has resigned, effective 28th February 2025, due to repatriation to Bayer AG. Dr. Miriam Holstein, Non-Executive Director, has also resigned, effective the same date. The company has appointed Mr. Vinit Rajesh Jindal as Whole-Time Director & CFO from 1st March 2025, and Ms. Jana Marlen Ackermann as Non-Executive Director from the same date.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
